Parkinson's Disease (PD) is a progressive neurodegenerative disorder primarily affecting the motor system. Characterized by bradykinesia, rigidity, and resting tremors, PD presents a complex clinical picture that is often challenging to manage.
PD is the second most common neurodegenerative disorder, affecting approximately 1% of individuals over the age of 60. Risk factors include age, male gender, and exposure to certain environmental toxins. Genetic predisposition also plays a role, with several mutations identified.
PD is characterized by the loss of dopaminergic neurons in the substantia nigra, leading to an imbalance in the basal ganglia's output. The exact cause of this neuronal death remains unclear, but it is thought to involve a combination of genetic and environmental factors.
PD typically presents with resting tremor, bradykinesia, and rigidity. Non-motor symptoms such as depression, constipation, and cognitive impairment are also common. Diagnosis is primarily clinical, supported by response to dopaminergic therapy.
Management of PD is symptomatic, with levodopa being the most effective medication for motor symptoms. Non-pharmacological interventions, including physical therapy and deep brain stimulation, may also be beneficial. Regular follow-up is essential to monitor disease progression and adjust treatment accordingly.
PD is a chronic disease with a variable course. Most patients experience a gradual progression of symptoms over many years. Prognosis is influenced by age at onset, severity of symptoms, and response to treatment.
Understanding the complexities of PD is crucial for optimal patient management. As healthcare professionals, we must stay abreast of the latest research to provide the best possible care for our patients with PD.
1.
Health researchers discuss Medicaid cancer screening trends, best practices
2.
Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma
3.
Approved BTK Inhibitor Without Covalent Bond for CLL.
4.
Genomic Newborn Screening Could Identify Childhood Cancer Predisposition
5.
AI-based breast cancer risk technology receives FDA breakthrough device designation
1.
Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms
2.
Innovative Solutions in Hematology for Specialists
3.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
4.
Carboplatin Treatment: What You Need to Know About Side Effects and Efficacy
5.
Evidence-Based Insights in Oncology for Specialists
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
2.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
3.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
5.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation